Liraglutide confers neuroprotection in obese patients with diabetes
15 Jun 2020
byJairia Dela Cruz
The glucagon-like peptide-1 receptor agonist (GLP1-RA) liraglutide helps prevent and/or reverse memory function decline in obese patients with prediabetes or early type 2 diabetes mellitus (T2DM), whereas a lifestyle intervention produces improvements in attentive functions, a study has shown.